Please assess the completion status of the following clinical trial:

Trial Title: A Study of Acne Treatment in Children Ages 9 to 11

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and non-pregnant, non-nursing females, 9 to 11 years, with facial pediatric acne vulgaris~* Minimum of 20 non-inflammatory lesions (open and closed comedones)~* Minimum of 30 total facial lesions (sum of inflammatory and non-inflammatory)~* Must have at least a rating of grade 3 on the Investigator Global Assessment Scale for acne severity (IGA #1) at baseline~Exclusion Criteria:~* Known sensitivity to any of the ingredients in the study medication;~* Any nodulocystic acne lesions~* Use of acne devices or systemic therapy with antibiotics within two months prior to start and throughout the duration of the study~* Use of systemic therapy with retinoids within four months prior to study start and throughout the duration of the study~* Topical use of topical retinoids within two weeks prior to study start and throughout the duration of the study~* Topical use of antibiotics, steroids and/or other non-retinoid topical acne products within two weeks prior to study start and throughout the duration of the study~* Use of an experimental drug or device within 60 days prior to study start;~* Use of hormonal therapy within 3 months prior to study start~* History of evidence of other skin conditions or diseases that may require concurrent therapy or may interfere with the evaluation of the study medication~* Any significant medical conditions that could confound the interpretation of the study~* History of/or current facial skin cancer~* Inability to refrain from use of all facial products other than those supplied by the study, while participating in the study~* No use of tanning booths, sun lamps, etc.~* Subject is a family member of the employee or the investigator

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Retin-A Micro (Type: EXPERIMENTAL): Retin-A Micro 0.04% facial acne treatment used once daily
- Vehicle Control (Type: PLACEBO_COMPARATOR): Color matched facial gel vehicle control used once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).